Estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) are reportedly accurate and independent prognostic indicators of breast cancer recurrence risk [6], and combining these independent indicators can improve accuracy in predicting recurrence. This evidence concerns the gene ERBB2 and breast cancer.